While prior literature classifies AP3B2 antibody-associated sensory disturbances as sensory neuropathy (4), we propose that cases presenting solely with sensory deficits (e.g., limb numbness) should be more appropriately classified as AP3B2 antibody-associated SN to reflect precise clinicopathological correlation. The gene discussed is AP3B2; the disease is Sensory neuropathy.